Market: NMS |
Currency: USD
Address: 4660 La Jolla Village Drive
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.
📈 Revelation Biosciences, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$53.00
-
Upside/Downside from Analyst Target:
8,105.60%
-
Broker Call:
2
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
2026-05-08
-
EPS Estimate:
-1.15
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Revelation Biosciences, Inc.
| Date | Reported EPS |
|---|
| 2026-05-07 (estimated upcoming) | - |
| 2026-02-26 | -1.65 |
| 2025-11-06 | -7.08 |
| 2025-08-08 | -28.04 |
| 2025-05-08 | -25.32 |
| 2025-03-06 | -59.76 |
| 2024-11-08 | -161.28 |
| 2024-08-09 | -984.96 |
| 2024-05-10 | -472.32 |
| 2024-03-22 | -6859.07 |
| 2023-11-09 | -2488.78 |
| 2023-08-11 | -1854.72 |
| 2023-05-22 | -2913.41 |
| 2023-03-30 | -12904.14 |
| 2022-11-10 | -12096.03 |
| 2022-08-15 | -24192.05 |
| 2022-05-16 | -94752.2 |
📰 Related News & Research
🔍 View more Reports
